Role of modeling in pharmacotherapeutics | p. 3 |
PET and nuclear medicine imaging of the breast | p. 31 |
Functional radiologic imaging in breast cancer | p. 43 |
Prevention of breast cancer | p. 63 |
DCIS : pathology and molecular markers | p. 99 |
Ductal carcinoma in situ : a modern approach to patient management | p. 125 |
Ductal carcinoma in situ : systemic treatment | p. 137 |
Tailored surgery for early breast cancer : surgical techniques | p. 161 |
Tailored surgery for early breast cancer : biological aspects | p. 183 |
Tailored surgery for early breast cancer : the very young woman | p. 199 |
Tailored surgery for older women with breast cancer | p. 215 |
Tailored radiotherapy for breast cancer stages I and II : technical aspects | p. 235 |
Breast cancer management in the era of molecular medicine : tailored radiotherapy - clinical and biological aspects | p. 257 |
Early breast cancer (stage I and II) : tailored radiotherapy for very young women | p. 279 |
The elderly and breast cancer radiotherapy | p. 291 |
Early breast cancer (stage I and stage II) : tailored systemic therapy for endocrine-resistant breast cancer | p. 309 |
Early breast cancer (stage I and stage II) : tailored systemic therapy for endocrine-responsive breast cancer | p. 327 |
Tailored therapy for breast cancer in very young women | p. 349 |
Tailored systemic therapy for the elderly woman | p. 375 |
Locoregional therapy following neoadjuvant chemotherapy : an evolving paradigm of treatment individualization | p. 401 |
Medical therapy of locally advanced breast cancer | p. 427 |
Metastatic breast cancer : tailored endocrine therapy for premenopausal women | p. 451 |
Metastatic breast cancer : tailored endocrine therapy for postmenopausal women | p. 465 |
Metastatic breast cancer : tailored chemotherapy for the elderly woman | p. 479 |
Treatment of brain metastases from breast cancer | p. 505 |
Surgical management of breast cancer liver metastases | p. 525 |
Individualization of bisphosphonate therapy | p. 545 |
Breast cancer metastases to the eye | p. 565 |
Organ-specific approaches : pain management | p. 569 |
Genomic and molecular classification of breast cancer | p. 595 |
Applications of proteomics to clinical questions in breast cancer | p. 623 |
Targeting the HER family of receptors in the treatment of advanced breast cancer | p. 643 |
Biological therapies for metastatic breast cancer : antiangiogenesis | p. 671 |
Breast cancer gene therapy | p. 705 |
Innovative rational-derived, target-based and cytotoxic therapies for breast cancer and other malignancies | p. 741 |
Mechanisms of breast cancer resistance to chemotherapy | p. 783 |
Mechanisms of resistance to hormone therapy | p. 805 |
Novel signaling pathways in breast cancer | p. 823 |
Mechanisms of apoptosis resistance in breast cancer | p. 841 |
Breast cancer and pregnancy | p. 863 |
Hormone replacement therapy after breast cancer | p. 879 |
Male breast cancer | p. 903 |
Patients' preferences : what makes treatments worthwhile? | p. 925 |
Breast cancer : the impact of depression and its treatment | p. 945 |
Molecular profiling in breast cancer | p. 977 |
Clinical trials in the era of treatment tailoring | p. 1007 |
Table of Contents provided by Blackwell. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.